COMMUNIQUÉS West-GlobeNewswire

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 46 - 2025
19/11/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 10 Novembre au 14 Novembre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
Aeroflow Health Named to The Healthcare Technology Report's Top 50 Healthcare Technology Companies of 2025
19/11/2025
Recognition Highlights Company's Technology Platform That Expands Healthcare Access for Millions of Members Nationwide ASHEVILLE, N.C., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Aeroflow Health , a healthcare company pioneering [...]
SimpleTherapy Recognized as a Top 50 Healthcare Technology Company of 2025
19/11/2025
FRESNO, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- SimpleTherapy, a leader in virtual musculoskeletal (MSK) and behavioral health care solutions, is honored to be named one of The Healthcare Technology Report’s Top 50 [...]
Humber River Health 10th Anniversary Event Raises Over $2.55 Million to Power the Next Decade of Innovation and Patient-Centered Care
19/11/2025
TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- On Friday, November 14, more than 800 guests came together to party with a purpose at The International Centre for a dazzling night of celebration, generosity, and inspiration [...]
Curaechoice Announces Nationwide Expansion of $0-Cost Vision Care Program
19/11/2025
All Members and Their Families Gain Access to Vision Services Nationwide Beginning Jan. 1, 2026 Birmingham, Alabama, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Curaechoice , the nation’s #1 leader in no-cost benefits [...]
Dr. Charles Ruotolo Advances Patient-Focused Orthopedic and Sports Medicine Services
19/11/2025
Known for clinical skill and compassionate care, Dr. Charles Ruotolo leads the team at Total Orthopedics and Sports Medicine. With 14 locations across New York and more than 20 board-certified physicians, the practice [...]
Scientific Industries to Host Third Quarter Fiscal Year 2025 Financial Results Investor Call on November 20, 2025
19/11/2025
Investor Call to be held at 11:00 AM Eastern Time BOHEMIA, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Scientific Industries, Inc. (OTCQB: SCND), a developer of digitally simplified bioprocessing products and vision-based [...]
Longeveron Laromestrocel Data in Alzheimer’s Disease Selected for Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD 2025)
19/11/2025
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, [...]
Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027
19/11/2025
All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T program Acquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR ⍺ Antagonist, Phase 3-ready) and TPST-1495 (Dual Ep2/4 [...]
Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology
19/11/2025
November 19, 2025 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an extended partnership with Cortechs.ai , a pioneer in quantitative [...]
Vaso Corporation Announces Divestiture of Subsidiary
19/11/2025
Vaso Corporation 137 Commercial Street Plainview, New York 11803 Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact: Jonathan Newton Investor Relations Phone: 516-997-4600 Email: jnewton@vasocorporation.com [...]
FibroBiologics Announces Pricing of $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
19/11/2025
HOUSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the [...]
Nanox Reaches Agreement with Vaso Corporation to Acquire VasoHealthcare IT, Accelerating U.S. Rollout of AI Solutions
19/11/2025
PETACH TIKVA, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“Nanox” or the “Company”, Nasdaq: NNOX), an innovative medical imaging technology company, today announced that the parties have agreed on the [...]
TELA Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
19/11/2025
MALVERN, Pa., Nov. 19, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the [...]
Minerva Neurosciences Appoints Dr. Inderjit Kaul to the Company’s Board of Directors
19/11/2025
BURLINGTON, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system [...]
CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference
19/11/2025
MINNEAPOLIS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th
19/11/2025
MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (Nasdaq: RNXT) (“RenovoRx” or “the Company”), a life sciences company developing innovative targeted oncology therapies and commercializing [...]
Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million
19/11/2025
Service agreement and financing facility supports strategic growth and commercialization initiatives LAS VEGAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTCQB: ODYY), a medical device company focused on [...]
Vivos Therapeutics Schedules Release of Third Quarter 2025 Financial Results and Conference Call
19/11/2025
Call scheduled for today, Wednesday, November 19, 2025, at 5:00 pm ET LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a leading medical device and [...]

Pages